Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary nationwide Class I recall of Symbiq™ infusion systems (list number 16026 Symbiq™ One-Channel Infuser and list number 16027 Symbiq™ Two-Channel Infuser, all serial numbers). This action is due to infusion pump LCD touch screens that may not respond to user selection, resulting in users possibly experiencing a delayed response and/or the screen registering a different value from the value selected by the user.
This is a summary of a recall issued by the Food and Drug Administration (FDA). The link below will take you to the original recall press release containing complete information, including instructions about what to do if you are affected by this recall.
View Full Details Of Original FDA Recall Notice Here.
